Special Notice NAICS 541714

Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)

🏢 HEALTH AND HUMAN SERVICES, DEPARTMENT OF 📅 Posted 2025-09-25 ⏳ Due 2025-10-01T03:59:00+00:00
This Special Notice (SN) is intended to alert the scientific community to a newly approved ARPA-H Program and notify potential proposers of an associated Proposers’ Day (PD). Under the cognizance of HSF, ARPA-H is publishing an Innovative Solutions Opening (ISO) for the Treating Hereditary Rare diseases with In Vivo precision genetic mEdicines (THRIVE) program no later than September 25, 2025, please monitor SAM.gov for updates (ARPA-H-SOL-25-122). For additional PD details and registration information see the attached special notice (ARPA-H-SN-25-131). For more information about the THRIVE program visit: https://arpa-h.gov/explore-funding/programs/thrive

Notice ID: 158c111f6a0d4952b97419c6dccc068c · View on SAM.gov ↗

Explore more federal-contracting data

Browse opportunities by NAICS code · set-aside category · state & jurisdiction · buying agency

Win more federal contracts

BidChamp gives small businesses AI-powered bid writing, document analysis, and recompete forecasting - for free during your trial.

Sign up free - 14-day trial, no card required